Advertisement

Acta Chirurgica Austriaca

, Volume 29, Issue 5, pp 248–250 | Cite as

Pathomorphologie und Entstehungsfaktoren des Pankreaskarzinoms

  • A. Zimmermann
Themenschwerpunkt: Pankreaskarzinom: Aktuelles Aus Der Grundlagenforschung Und Neue Konzepte Zur Therapie
  • 16 Downloads

Zusammenfassung

Grundlagen: Pankreatische Neoplasmen nehmen ihren Ursprung von exokrinen und endokrinen Komponenten des Pankreas, seltener vom fibrovaskulären Stroma.

Methodik: Diese Übersicht beschränkt sich auf Tumoren des exokrinen Apparats, welche mehr als 90% der Neoplasmen des Pankreas stellen.

Ergebnisse: Es werden die wesentlichen Tumortypen gemäß ihrer morphologischen Präsentation und ihrer klinischen Relevanz diskutiert, und es wird auch kurz auf seltenere neoplastische Prozesse eingegangen. Ferner werden Faktoren, die bei der Entstehung von Pankreaskarzinomen eine Rolle spielen, besprochen.

Schlußfolgerungen: Die Pathomorphologie gibt Hinweise auf die Prognose, das Erkennen von möglichen Entstehungsfaktoren kann vielleicht in Zukunft das Pankreaskarzinom verhindern.

Schlüsselwörter

Pankreaskarzinom Pankreastumoren pankreatische Karzinogenese 

Morphology and pathogenic factors of pancreatic carcinoma

Summary

Background: Pancreatic cancers take their origin from exocrine and endocrine components of the pancreas, less frequently from fibrovascular tissues.

Methods: In the present review, emphasis is placed on tumors of the exocrine apparatus covering more than 90% of pancreatic neoplasms.

Results: Predominant tumor types are discussed with respect to their morphology and their clinical relevance, and rare neoplastic lesions are briefly presented. In addition, factors involved in pancreatic carcinogenesis are reviewed.

Conclusions: The pathomorphology offers hints for the prognosis, the knowledge of possible carcinogenic factors may prevent pancreatic cancer in future.

Key-words

Pancreatic cancer pancreatic tumors pancreatic carcinogenesis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. (1).
    Barton CM, Stoddon SL, Hughes CM: Abnormalities of the p53 tumor suppressor gene in human pancreatic cancer. Br J Cancer 1991;64:1076–1082.PubMedGoogle Scholar
  2. (2).
    Bergmann U, Funatomi H, Yokoyama M, Berger HG, Korc M: Insulin-like growth factor I overexpression in human pancreatic cancer: Evidence for autocrine and paracrine roles. Cancer Res 1995;55:2007–2011.PubMedGoogle Scholar
  3. (3).
    Boor PJ, Swanson MR: Papillary-cystic neoplasm of the pancreas. Am J Surg Pathol 1979;3:69–75.PubMedCrossRefGoogle Scholar
  4. (4).
    Cubilla AL, Fitzgerald PJ: Tumors of the Exocrine Pancreas. Atlas of Tumor Pathology. Second series, fascicle 19. Washington D.C., Armed Forces Institute of Pathology, 1984.Google Scholar
  5. (5).
    Day JD, DiGiuseppe JA, Yeo C, Laigoldman M, Anderson SM, Goodman SN, Kern SE, Hruban RH: Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum Pathol 1996;27:119–124.PubMedCrossRefGoogle Scholar
  6. (6).
    DiGiuseppe JA, Hruban RH, Goodman SN, Polak M, Van den Berg FM, Allison DC, Cameron JL, Offerhaus GJA: Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994;101:684–688.PubMedGoogle Scholar
  7. (7).
    DiRenzo MF, Poulsom R, Olivero M, Comoglio PM, Lemoine NR: Expression of the met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 1995;55:1129–1138.Google Scholar
  8. (8).
    Frantz VK: Tumors of the pancreas. In Atlas of tumor pathology VII. Fascicles 27 and 28. Washington D.C., Armed Forces Institute of Pathology, 1959.Google Scholar
  9. (9).
    Friess H, Yamanaka Y, Büchler M, Kobrin MS, Tahara E, Korc M: Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis. Int J Cancer 1994;56:668–674.PubMedCrossRefGoogle Scholar
  10. (10).
    Furukawa T, Chiba R, Kobari M, Matsuno S, Nagura H, Takahashi T: Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen. Arch Pathol Lab Med 1994;118:227–234.PubMedGoogle Scholar
  11. (11).
    Hruban RH, Van Mansfeld ADM, Offerhaus GJA, Van Weering DHJ, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL: K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545–554.PubMedGoogle Scholar
  12. (12).
    Kayahara M, Nagakawa T, Koniashi I, Ueno K, Ohta T, Miyazaki I: Clinicopathological study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus. Int J Pancreatol 1991;10:105–111.PubMedGoogle Scholar
  13. (13).
    Klöppel G, Lingenthal G, von Bülow M, Kern HF: Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xenografted tumours and clinicopathological correlation of 75 cases. Histopathology 1985;9:841–856.PubMedCrossRefGoogle Scholar
  14. (14).
    Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH: In collaboration with pathologists in 7 countries: Histological Typing of Tumours of the Exocrine Pancreas. 2nd ed. World Health Organization. Berlin-Heidelberg, Springer-Verlag, 1996.Google Scholar
  15. (15).
    Kobrin MS, Yamanaka Y, Friess H, Lopez ME, Korc M: Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res 1993;53:4741–4744.PubMedGoogle Scholar
  16. (16).
    Longnecker DS: The quest for preneoplastic lesions in the pancreas. Editorial. Arch Pathol Lab Med 1994;118:226.Google Scholar
  17. (17).
    Longnecker DS, Pettengill OS, Davis BH, Schaeffer BK, Zurlo J, Hong L, Kuhlmann ET: Characterization of preneoplastic and neoplastic lesions in the rat pancreas. Am J Pathol 1991;138:333–340.PubMedGoogle Scholar
  18. (18).
    Meduri F, Diana F, Merenda R, Losacco L, Zuin A, Cecchetto A, Gerunda GE, Neri D, Zangrandi F, Maffei-Faccioli A: Pancreatic cancer and retroperitoneal neural tissue invasion. Its implication for survival following radical surgery. Zbl Pathol 1994;140:277–279.Google Scholar
  19. (19).
    Morohoshi T, Kanda M, Asanuma K, Klöppel G: Intraductal papillary neoplasm of the pancreas: A clinicopathologic study of six patients. Cancer 1989;64:1329–1335.PubMedCrossRefGoogle Scholar
  20. (20).
    Nagakawa T, Kobayashi H, Ueno K, Ohta T, Kayahara M, Mori K, Nakano T, Takeda T, Konishi I, Miyazaki I: The pattern of lymph node involvement in carcinoma of the head of the pancreas. A histologic study of the surgical findings in patients undergoing extensive nodular dissections. Int J Pancreatol 1993;13:15–22.PubMedGoogle Scholar
  21. (21).
    Nishihara K, Fukuda T, Tsuneyoshi M, Kominami T, Maeda S, Saku M: Intraductal papillary neoplasm of the pancreas. Cancer 1993;72:689–696.PubMedCrossRefGoogle Scholar
  22. (22).
    Nishihara K, Nagoshi M, Tsuneyoshi M, Yamaguchi K, Hayashi I: Papillary cystic tumors of the pancreas. Assessment of their malignant potential. Cancer 1993;71:82–92.PubMedCrossRefGoogle Scholar
  23. (23).
    Santini D, Campione O, Salerno A, Gullo L, Mazzoleni G, Leone O, Martinelli G, Marrano D: Intraductal papillary-mucinous neoplasm of the pancreas. A clinicopathologic entity. Arch Pathol Lab Med 1995;119:209–213.PubMedGoogle Scholar
  24. (24).
    Shimizu M, Manabe T: Mucin-producing pancreatic tumors; Histological review of its nosological concept. Zbl Pathol 1994;140:211–223.Google Scholar
  25. (25).
    Shyr YM, Su C, Tsay SH, Lui WY: Mucin-producing neoplasms of the pancreas: Intraductal papillary and mucinous cystic neoplasms. Ann Surg 1996;223:14–146.CrossRefGoogle Scholar
  26. (26).
    Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y, Kawabe T, Yoshida H, Machinami R, Kishi K, Omata M: Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroentrology 1996;110:227–231.CrossRefGoogle Scholar
  27. (27).
    Yamanaka Y, Friess H, Büchler MW, Beger HG, Uchida E, Onda M, Kobrin MS, Korc M: Overexpression af acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993;53:5289–5296.PubMedGoogle Scholar
  28. (28).
    Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T, Sugano H, Kato Y: Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953–956.PubMedGoogle Scholar
  29. (29).
    Yokoyama M, Ebert M, Funatomi H, Friess H, Büchler MW, Johnson GR, Korc M: Amphiregulin is a potent mitogen in human pancreatic cancer cells: Correlation with patient survival. Int J Oncol 1995;6:625–631.Google Scholar
  30. (30).
    Yokoyama M, Funatomi H, Hope C, Damm D, Friess H, Büchler MW, Abraham J, Korc M: Heparin-binding EGF-like growth factor expression and biological action in human pancreatic cancer cells. Int J Oncol 1996;8:289–295.Google Scholar

Copyright information

© Blackwell Science Ltd 1997

Authors and Affiliations

  • A. Zimmermann
    • 1
  1. 1.Pathologisches InstitutUniversität Bern (Inselspital)BernSchweiz

Personalised recommendations